Rong Li, PhD, is now serving as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences.
Li is a recognized cancer biology researcher. His work has primarily focused on answering important questions concerning breast cancer treatment and prevention, including how BRCA1 suppresses tumors in gender- and tissue-specific manners, how tumor-inhibiting estrogen receptor β can be mobilized, and how adipose stromal cells can promote breast cancer progression.
Li came to GW from the University of Texas Health Science Center at San Antonio, where he was professor in the Department of Molecular Medicine and co-leader for the Cancer Development and Progression Program at the NCI-designated cancer therapy and research center, Mays Cancer Center.
